Biocon falls nearly 6% on USFDA observations for Bengaluru facility
Following the drop in the stock price, the company's market valuation went down by Rs 2,202 crore to Rs 37,608 crore.
May 03, 2018, 17:15 PM IST
Biocon surges 14% on USFDA nod for biosimilar of cancer drug
Shares of Biocon on Monday surged as much as 14 percent in morning trade after the biotechnology major said it has received regulatory approval to market a biosimilar of cancer drug Herceptin in the United States.
Dec 04, 2017, 12:17 PM IST
Biocon stocks gain over 5%, hit 52-week high in intra-day trade
Stocks of biotechnology major Biocon on Thursday surged over 5 percent after the company launched advanced novel therapy for the treatment of Hepatitis C at low cost.
Dec 24, 2015, 18:02 PM IST
Biocon shares end higher as arm Syngene gets Sebi nod for IPO
After surging 2.93 percent to Rs 460 in intraday trade, shares of Biocon ended at Rs 453.75, up 1.53 percent on the BSE.
Jun 16, 2015, 18:37 PM IST
Biocon shares gain 3% as arm Syngene gets Sebi nod for IPO
As per the draft papers, the company plans to sell 22 million equity shares, including reservation of up to two million shares for Biocon shareholders, through an offer for sale. Of the total shares on offer, 50 percent has been reserved for qualified institutional buyers, 15 percent for high net worth individuals and the rest for retail investors.
Jun 16, 2015, 12:41 PM IST
